Addition of a total pancreatectomy and pancreas transplantation in a liver transplant recipient with intraductal papillary mucinous neoplasm of the pancreas

Jonathan A. Fridell, Rodrigo Vianna, Richard S. Mangus, Marwan Kazimi, Edward Hollinger, A. Joseph Tector

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are increasingly recognized in clinical practice. There are no published data suggesting a management approach for the potential organ transplant recipient with the incidental finding of this pre-malignant lesion. Method: The recipient was a 65-yr-old man with hepatocellular carcinoma in a background of Laennec's cirrhosis. During evaluation for transplant, he was found to have diffuse IPMN. This patient underwent liver transplantation with a planned simultaneous total native pancreatectomy and pancreas transplant from the same donor. Results: The patient has had normal liver function and has been free of diabetes and exocrine insufficiency at 18 months post-transplant. Conclusion: IPMN in the potential transplant recipient should be managed more aggressively than in the general population because these patients will be committed to life-long immunosuppression. If a total pancreatectomy is contemplated, this is a unique opportunity to replace the pancreas with an allograft at the time of transplantation.

Original languageEnglish (US)
Pages (from-to)681-684
Number of pages4
JournalClinical Transplantation
Volume22
Issue number5
DOIs
StatePublished - 2008
Externally publishedYes

Fingerprint

Pancreas Transplantation
Pancreatectomy
Pancreatic Neoplasms
Transplants
Liver
Pancreas
Incidental Findings
Liver Transplantation
Immunosuppression
Allografts
Hepatocellular Carcinoma
Neoplasms
Fibrosis
Transplantation
Tissue Donors
Transplant Recipients
Population

ASJC Scopus subject areas

  • Transplantation

Cite this

Addition of a total pancreatectomy and pancreas transplantation in a liver transplant recipient with intraductal papillary mucinous neoplasm of the pancreas. / Fridell, Jonathan A.; Vianna, Rodrigo; Mangus, Richard S.; Kazimi, Marwan; Hollinger, Edward; Joseph Tector, A.

In: Clinical Transplantation, Vol. 22, No. 5, 2008, p. 681-684.

Research output: Contribution to journalArticle

Fridell, Jonathan A. ; Vianna, Rodrigo ; Mangus, Richard S. ; Kazimi, Marwan ; Hollinger, Edward ; Joseph Tector, A. / Addition of a total pancreatectomy and pancreas transplantation in a liver transplant recipient with intraductal papillary mucinous neoplasm of the pancreas. In: Clinical Transplantation. 2008 ; Vol. 22, No. 5. pp. 681-684.
@article{ccd6ecacf0eb42378d7c80941d838cfb,
title = "Addition of a total pancreatectomy and pancreas transplantation in a liver transplant recipient with intraductal papillary mucinous neoplasm of the pancreas",
abstract = "Background: Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are increasingly recognized in clinical practice. There are no published data suggesting a management approach for the potential organ transplant recipient with the incidental finding of this pre-malignant lesion. Method: The recipient was a 65-yr-old man with hepatocellular carcinoma in a background of Laennec's cirrhosis. During evaluation for transplant, he was found to have diffuse IPMN. This patient underwent liver transplantation with a planned simultaneous total native pancreatectomy and pancreas transplant from the same donor. Results: The patient has had normal liver function and has been free of diabetes and exocrine insufficiency at 18 months post-transplant. Conclusion: IPMN in the potential transplant recipient should be managed more aggressively than in the general population because these patients will be committed to life-long immunosuppression. If a total pancreatectomy is contemplated, this is a unique opportunity to replace the pancreas with an allograft at the time of transplantation.",
author = "Fridell, {Jonathan A.} and Rodrigo Vianna and Mangus, {Richard S.} and Marwan Kazimi and Edward Hollinger and {Joseph Tector}, A.",
year = "2008",
doi = "10.1111/j.1399-0012.2008.00863.x",
language = "English (US)",
volume = "22",
pages = "681--684",
journal = "Clinical Transplantation",
issn = "0902-0063",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Addition of a total pancreatectomy and pancreas transplantation in a liver transplant recipient with intraductal papillary mucinous neoplasm of the pancreas

AU - Fridell, Jonathan A.

AU - Vianna, Rodrigo

AU - Mangus, Richard S.

AU - Kazimi, Marwan

AU - Hollinger, Edward

AU - Joseph Tector, A.

PY - 2008

Y1 - 2008

N2 - Background: Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are increasingly recognized in clinical practice. There are no published data suggesting a management approach for the potential organ transplant recipient with the incidental finding of this pre-malignant lesion. Method: The recipient was a 65-yr-old man with hepatocellular carcinoma in a background of Laennec's cirrhosis. During evaluation for transplant, he was found to have diffuse IPMN. This patient underwent liver transplantation with a planned simultaneous total native pancreatectomy and pancreas transplant from the same donor. Results: The patient has had normal liver function and has been free of diabetes and exocrine insufficiency at 18 months post-transplant. Conclusion: IPMN in the potential transplant recipient should be managed more aggressively than in the general population because these patients will be committed to life-long immunosuppression. If a total pancreatectomy is contemplated, this is a unique opportunity to replace the pancreas with an allograft at the time of transplantation.

AB - Background: Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are increasingly recognized in clinical practice. There are no published data suggesting a management approach for the potential organ transplant recipient with the incidental finding of this pre-malignant lesion. Method: The recipient was a 65-yr-old man with hepatocellular carcinoma in a background of Laennec's cirrhosis. During evaluation for transplant, he was found to have diffuse IPMN. This patient underwent liver transplantation with a planned simultaneous total native pancreatectomy and pancreas transplant from the same donor. Results: The patient has had normal liver function and has been free of diabetes and exocrine insufficiency at 18 months post-transplant. Conclusion: IPMN in the potential transplant recipient should be managed more aggressively than in the general population because these patients will be committed to life-long immunosuppression. If a total pancreatectomy is contemplated, this is a unique opportunity to replace the pancreas with an allograft at the time of transplantation.

UR - http://www.scopus.com/inward/record.url?scp=52649145308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52649145308&partnerID=8YFLogxK

U2 - 10.1111/j.1399-0012.2008.00863.x

DO - 10.1111/j.1399-0012.2008.00863.x

M3 - Article

C2 - 18627400

AN - SCOPUS:52649145308

VL - 22

SP - 681

EP - 684

JO - Clinical Transplantation

JF - Clinical Transplantation

SN - 0902-0063

IS - 5

ER -